Kavi Asset Management, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Kavi Asset Management, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$14,899,000
+55.6%
609,615
+65.2%
9.73%
+91.6%
Q4 2018$9,573,000
-50.0%
369,030
-39.0%
5.08%
-36.0%
Q3 2018$19,151,000
+47.4%
605,076
+81.0%
7.93%
+100.3%
Q2 2018$12,989,000
+121.1%
334,331
+57.0%
3.96%
+85.7%
Q1 2018$5,876,000212,9002.13%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders